{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:01:34Z","timestamp":1773730894810,"version":"3.50.1"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"6","funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PHATI Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2016,6,6]]},"DOI":"10.1021\/acs.molpharmaceut.6b00077","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T15:59:20Z","timestamp":1462291160000},"page":"1927-1936","source":"Crossref","is-referenced-by-count":35,"title":["Toward Biopredictive Dissolution for Enteric Coated Dosage Forms"],"prefix":"10.1021","volume":"13","author":[{"given":"J.","family":"Al-Gousous","sequence":"first","affiliation":[{"name":"Institute\rof Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Staudinger\rWeg 5, 55099 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Amidon","sequence":"additional","affiliation":[{"name":"Department\rof Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Langguth","sequence":"additional","affiliation":[{"name":"Institute\rof Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Staudinger\rWeg 5, 55099 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"ref1\/cit1","first-page":"39","volume-title":"Polymers for Controlled Drug Delivery","author":"Agyilirah G. A.","year":"1991"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.14227\/DT220315P6"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.14227\/DT110204P6"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.05.012"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00871-7"},{"issue":"6","key":"ref6\/cit6","first-page":"565","volume":"141","author":"Rudinskas L.","year":"1989","journal-title":"Can. Med. Assoc. J."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2012.07.011"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.05.007"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.09.009"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.01.007"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.09.003"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2013.09.020"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1021\/mp800148u"},{"key":"ref14\/cit14","unstructured":"FDA. Guidance for Industry: Bionalytical Method Validation; 2001."},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012102522787"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600570807"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600610312"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558267"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S47895"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90160-6"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23212"},{"key":"ref22\/cit22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/B978-0-444-53242-8.00016-3","volume-title":"Developing Solid Oral Dosage Forms: Pharmaceutical theory & Practice","author":"Zhou H.","year":"2009"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106217"},{"key":"ref24\/cit24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0021-9258(18)45087-9","volume":"142","author":"McGee L. C.","year":"1942","journal-title":"J. Biol. Chem."},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.8.1035"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24274"},{"issue":"1","key":"ref27\/cit27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9258(18)43200-0","volume":"155","author":"Bucher G. R.","year":"1944","journal-title":"J. Biol. Chem."},{"key":"ref28\/cit28","unstructured":"FDA. Guidance for Industry: Extended Release Dosage Forms: Development, Evaluation and Application of in vitro\/in vivo correlations; 1997."},{"key":"ref29\/cit29","unstructured":"Amer, M. S.Low-dose sublingual aspirin; Patent US4866046 A. 1989."},{"issue":"10","key":"ref30\/cit30","first-page":"394","volume":"29","author":"Endrenyi L.","year":"1991","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02683.x"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6b00077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T17:52:44Z","timestamp":1682617964000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.6b00077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6,6]]}},"alternative-id":["10.1021\/acs.molpharmaceut.6b00077"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00077","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}